Mode
Text Size
Log in / Sign up
Phase 4 Completed N=204 Prevention

Intravenous Oliceridine and Opioid-related Complications

Major Surgery
Source: ClinicalTrials.gov NCT04979247 ↗
Enrolled (actual)
204
Serious AEs
0.0%
Results posted
May 2026
Primary outcomePrimary: Clinically Meaningful Respiratory Compromise Events — 45 Events
◆ Published Evidence
Emerging
14citations · ~14 / year
Oliceridine for postoperative pain and opioid-related complications: The intravenous oliceridine and opioid-related complications (VOLITION) prospective cohort study.
Journal of clinical anesthesia · 2025 · Likely link

Summary

The investigator will evaluate the side effects of oliceridine.

Linked Publications

  • Oliceridine for postoperative pain and opioid-related complications: The intravenous oliceridine and opioid-related complications (VOLITION) prospective cohort study.
    Journal of clinical anesthesia · 2025 · 14 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Clinically Meaningful Respiratory Compromise Events
45

Eligibility Criteria

Inclusion Criteria

  • ≥18 years old
  • American Society of Anesthesiologists physical status 1-4
  • Scheduled for major noncardiac surgery expected to last at least 2 hours
  • Expected to remain hospitalized at least two postoperative nights
  • Scheduled for general endotracheal, spinal anesthesia, or the combination
  • Expected to require substantial opioid analgesia, defined as ≥20 mg morphine equivalents
  • Expected to have patient-controlled intravenous analgesia.

Exclusion Criteria

  • Are demented or otherwise cannot provide valid consent
  • Have contraindications to oliceridine
  • Used legal or illegal opioids chronically, defined as >15 mg morphine equivalents for >15 days during the month before consenting by history
  • Have language, vision, or hearing impairments that may compromise continuous ventilation monitoring
  • Have planned epidural anesthesia/analgesia
  • Planned spinal morphine administration
  • Are designated Do Not Resuscitate, hospice, or receiving end of life therapy
  • Are expected to require postoperative mechanical ventilation or ICU admission
  • Are expected to receive intrathecal opioids
  • Are expected to receive gabapentin, pregabalin or other analgesic adjuvants
  • Use oxygen at home
  • Are unwilling or unable to comply fully with study procedures (including not tolerating the capnography cannula)
  • Are known to be pregnant or breastfeeding
  • Use CPAP at home
  • Have previously participated in the trial
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04979247) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search